An alternative method to validate surrogate endpoints in oncology
Abstract Background Surrogate endpoints are often utilized to support drug efficacy claims. Hence, it is of paramount importance to validate the effectiveness of surrogate endpoints in correctly predicting clinical benefit, in order to ensure a fast and safe access to new drugs. This study aimed to...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-03-01
|
| Edice: | BMC Medical Research Methodology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12874-026-02846-9 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|